Recurrence
Welcome,         Profile    Billing    Logout  
 99 Companies   136 Products   136 Products   122 Mechanisms of Action   5 Trials   1111 News 


«12345678910111213...1617»
  • ||||||||||  Biomarker, Trial completion:  ProFaCo: Prognostic Factors for All Types of Cancer Combined (clinicaltrials.gov) -  Apr 7, 2016   
    P=N/A,  N=520, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Jan 2017 Active, not recruiting --> Completed
  • ||||||||||  Cimzia (certolizumab pegol) / Astellas, UCB
    Enrollment closed, Enrollment change:  Cimzia Versus Mesalamine for Crohn's Recurrence (clinicaltrials.gov) -  Mar 17, 2016   
    P4,  N=10, Active, not recruiting, 
    Trial primary completion date: Feb 2016 --> Oct 2017 Recruiting --> Active, not recruiting | N=24 --> 10
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma (clinicaltrials.gov) -  Mar 16, 2016   
    P1/2,  N=31, Terminated, 
    Recruiting --> Active, not recruiting | N=24 --> 10 N=100 --> 31 | Recruiting --> Terminated | Trial primary completion date: Sep 2017 --> Mar 2016; PI left HMRI
  • ||||||||||  Enrollment closed, Trial primary completion date, Metastases:  Cyto-Cog: Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca (clinicaltrials.gov) -  Mar 9, 2016   
    P=N/A,  N=120, Active, not recruiting, 
    N=100 --> 31 | Recruiting --> Terminated | Trial primary completion date: Sep 2017 --> Mar 2016; PI left HMRI Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2013 --> Sep 2016
  • ||||||||||  5-fluorouracil / Generic mfg.
    Trial primary completion date, Surgery:  OCUM: Optimal Surgery and MRI Based Radiochemotherapy in Rectal Carcinoma (clinicaltrials.gov) -  Mar 5, 2016   
    P=N/A,  N=782, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2013 --> Sep 2016 Trial primary completion date: Dec 2015 --> Jun 2016
  • ||||||||||  venlafaxine extended release / Generic mfg., fluoxetine / Generic mfg.
    Trial completion:  Study Evaluating Venlafaxine ER in Recurrent Depression (clinicaltrials.gov) -  Feb 27, 2016   
    P4,  N=1096, Completed, 
    Recruiting --> Completed No longer recruiting --> Completed
  • ||||||||||  nortriptyline / Generic mfg.
    Trial completion:  Preventing the Return of Depression in Elderly Patients (clinicaltrials.gov) -  Feb 27, 2016   
    P=N/A,  N=0, Completed, 
    No longer recruiting --> Completed No longer recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Tumor cell:  Circulating Tumor Cells in Operative Blood (clinicaltrials.gov) -  Feb 24, 2016   
    P=N/A,  N=3, Completed, 
    Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Completed | N=20 --> 3
  • ||||||||||  trimethoprim/sulfamethoxazole / Generic mfg.
    Trial completion, Trial primary completion date:  ISROT: Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis (clinicaltrials.gov) -  Feb 13, 2016   
    P3,  N=141, Completed, 
    Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Oct 2011 --> Nov 2013
  • ||||||||||  Votrient (pazopanib) / Novartis, BeiGene
    Biomarker:  Neoadjuvant Pazopanib in Renal Cell Carcinoma (clinicaltrials.gov) -  Jan 20, 2016   
    P2,  N=21, Active, not recruiting, 
    Completed --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Jan 2017 Recruiting --> Active, not recruiting | N=56 --> 21
  • ||||||||||  Trial primary completion date:  FACBC for Recurrent Prostate Cancer (clinicaltrials.gov) -  Jan 19, 2016   
    P2,  N=25, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Oct 2016
  • ||||||||||  Civacir (hepatitis C immune globulin) / ADMA Biologics, Kedrion
    Enrollment closed, Trial primary completion date:  Civacir (clinicaltrials.gov) -  Jan 19, 2016   
    P3,  N=80, Active, not recruiting, 
    Trial primary completion date: Dec 2015 --> Oct 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Feb 2016
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    Enrollment closed, Enrollment change, Trial primary completion date:  Rituximab to Prevent Recurrence of Proteinuria (clinicaltrials.gov) -  Jan 16, 2016   
    P3,  N=43, Active, not recruiting, 
    Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Active, not recruiting | N=60 --> 43 | Trial primary completion date: Feb 2016 --> Feb 2017
  • ||||||||||  Enrollment closed, Metastases:  Non-Interventional Study PREVENT (clinicaltrials.gov) -  Jan 15, 2016   
    P=N/A,  N=200, Active, not recruiting, 
    Recruiting --> Active, not recruiting | N=60 --> 43 | Trial primary completion date: Feb 2016 --> Feb 2017 Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion:  Lamotrigine Phase III Study in Bipolar I Disorder (clinicaltrials.gov) -  Jan 12, 2016   
    P3,  N=265, Completed, 
    Recruiting --> Active, not recruiting Active, not recruiting --> Completed
  • ||||||||||  Enrollment change, Trial initiation date, Trial termination, Trial primary completion date, Tumor cell, Metastases:  Prognostic Value of CTC in HNSCC Patients (clinicaltrials.gov) -  Dec 12, 2015   
    P=N/A,  N=53, Terminated, 
    Active, not recruiting --> Completed N=300 --> 53 | Initiation date: Oct 2011 --> Jun 2012 | Recruiting --> Terminated | Trial primary completion date: Oct 2014 --> May 2015; participants are no longer being examined or treated
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Mucosal Versus Fecal Microbiota in FMT (clinicaltrials.gov) -  Dec 10, 2015   
    P=N/A,  N=10, Completed, 
    N=300 --> 53 | Initiation date: Oct 2011 --> Jun 2012 | Recruiting --> Terminated | Trial primary completion date: Oct 2014 --> May 2015; participants are no longer being examined or treated Recruiting --> Completed | N=20 --> 10 | Trial primary completion date: Jul 2016 --> Aug 2015
  • ||||||||||  Trial completion:  Mesalazine Effects in Sporadic Colorectal Adenoma Patients (clinicaltrials.gov) -  Dec 9, 2015   
    P2,  N=74, Completed, 
    Recruiting --> Completed | N=20 --> 10 | Trial primary completion date: Jul 2016 --> Aug 2015 Recruiting --> Completed